Variations in genes regulating neuronal migration predict reduced prefrontal cognition in schizophrenia and bipolar subjects from mediterranean Spain: A preliminary study

Neuroscience

Volumn 139, Issue 4, 2006, Pages 1289-1300

  Tabares Seisdedos R ^a   Escamez T ^b   Martinez Gimenez J A ^a   Balanza V ^a   Salazar, J ^a   Selva, G ^a   Rubio, C ^a   Vieta, E ^c   Geijo Barrientos E ^b   Martinez Aran A ^c   Reiner, O ^d   Martinez S ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b INSTITUTO DE NEUROCIENCIAS   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

endophenotype; LIS1; lissencephaly; neuronal migration; platelet activating factor receptor; prefrontal cognition

Indexed keywords

THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE ACTIVATING FACTOR RECEPTOR;

ADULT; AGYRIA; ARTICLE; BIPOLAR DISORDER; CELL MIGRATION; CHROMOSOME 17P; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; GENE CONTROL; GENE EXPRESSION; GENETIC VARIABILITY; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; NEUROPSYCHOLOGICAL TEST; NUCLEOTIDE SEQUENCE; PREDICTION; PREDICTOR VARIABLE; PREFRONTAL CORTEX; PRIORITY JOURNAL; SCHIZOPHRENIA; SPAIN; STATISTICAL SIGNIFICANCE; WISCONSIN CARD SORTING TEST;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; BIPOLAR DISORDER; CELL MOVEMENT; CHROMOSOMES, HUMAN, PAIR 17; COGNITION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MOLECULAR BIOLOGY; NEURONS; NEUROPSYCHOLOGICAL TESTS; PLATELET ACTIVATING FACTOR; PREDICTIVE VALUE OF TESTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SPAIN;

EID: 33646489305     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2006.01.054     Document Type: Article

References (84)

1. Agarwala R., Applegate D.L., Maglott D., Schuler G.D., and Schaffer A.A. A fast and scalable radiation hybrid map construction and integration strategy. Genome Res 10 (2000) 350-364
2. Altman E.G., Hedeker D.R., Janicak P.G., Peterson J.L., and Davis J.M. The Clinician-Administered Rating Scale for Mania (CARS-M). development, reliability, and validity. Biol Psychiatry 36 (1994) 124-134
3. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition (1994), American Psychiatric Association, Washington, DC
4. Ardilla A., Roselli M., and Puente A. Neuropsychological evaluation of the Spanish speaker (2004), Plenum Press, New York
5. Assadi A.H., Zhang G., Beffert U., McNeil R.S., Renfro A.L., Niu S., et al. Interaction of reelin signaling and Lis1 in brain development. Nat Genet 35 (2003) 270-276
6. Balanzá-Martínez V., Tabarés-Seisdedos R., Selva-Vera G., Martinez-Aran A., Torrent C., Salazar-Fraile J., Leal-Cercós C., Vieta E., and Gómez-Beneyto M. Persistent cognitive dysfunctions in bipolar I disorder and schizophrenic patients. a 3-year follow-up study. Psychother Psychosom 74 (2005) 113-119
7. Batanian J.R., Ledbetter S.A., Wolff R.K., Nakamura Y., White R., Dobyns W.B., and Ledbetter D.H. Rapid diagnosis of Miller-Dieker syndrome and isolated lissencephaly sequence by the polymerase chain reaction. Hum Genet 85 (1990) 555-559
8. Bebbington P., and Nayani T. The psychosis screening questionnaire. Int J Methods Psychiatr Res 5 (1995) 11-19
9. Bell R., Collier D.A., Rice S.Q., Roberts G.W., MacPhee C.H., Kerwin R.W., et al. Systematic screening of the LDL-PLA2 gene for polymorphic variations and case-control analysis in schizophrenia. Biochem Biophys Res Commun 241 (1997) 630-635
10. Berrettini W.H. Bipolar disorders. review of molecular genetic linkage studies. In: Davis K.L., et al. (Ed). Neuropsychopharmacology, the fifth generation of progress (2002), Lippincott, Philadelphia 1028-1039
11. Bix G.J., and Clark G.D. Platelet-activating factor receptor stimulation disrupts neuronal migration in vitro. J Neurosci 18 (1998) 307-318
12. Blackwood D.H., Fordyce A., Walker M.T., St. Clair D.M., Porteous D.J., and Muir W.J. Schizophrenia and affective disorders-cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes. clinical and P300 findings in a family. Am J Hum Genet 69 (2001) 428-433
13. Brandon N.J., Handford E.J., Schurov I., Rain J.C., Pelling M., Duran-Jimeniz B., et al. Disrupted in Schizophrenia 1 and Nudel form a neurodevelopmentally regulated protein complex. implications for schizophrenia and other major neurological disorders. Mol Cell Neurosci 25 (2004) 42-55
14. Callicott J.H., Straub R.E., Pezawas L., Egan M.F., Mattay V.S., Hariri A.R., Verchinski B.A., Meyer-Lindenberg A., Balkissoon R., Kolachana B., Goldberg T.E., and Weinberger D.R. Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci U S A 102 (2005) 8627-8632
15. Cardoso C., Leventer R.J., Ward H.L., Toyo-oka K., Chung J., Gross A., et al. Refinement of a 400-kb critical region allows genotypic differentiation between isolated lissencephaly, Miller-Dieker syndrome, and other phenotypes secondary to deletions of 17p13.3. Am J Hum Genet 72 (2003) 918-930
16. Chen C., and Bazan N.G. Platelet-activating factor inhibits ionotropic GABA receptor activity in cultured hippocampal neurons. Neuroreport 10 (1999) 3831-3835
17. Chiu H.J., Wang Y.C., Chen J.Y., Hong C.J., and Tsai S.J. Association study of the p53-gene Pro72Arg polymorphism in schizophrenia. Psychiatry Res 105 (2001) 279-283
18. Citrome L., Goldberg J.F., and Sthal S.M. Toward convergence in the medication treatment of bipolar disorder and schizophrenia. Harv Rev Psychiatry 13 (2005) 28-42
19. Costa E., Guidotti A., and Veldic M. Should allosteric positive modulators of GABA(A) receptors be tested in the treatment of schizophrenia?. Schizophr Res 73 (2005) 367-368
20. Crow T.J. From Kraepelin to Kretschmer leavened by Schneider. the transition from categories of psychosis to dimensions of variation intrinsic to Homo sapiens. Arch Gen Psychiatry 55 (1998) 502-504
21. Daban C., Martínez-Arán A., Torrent C., Tabarés-Seisdedos R., Balanzá-Martínez V., Salazar-Fraile J., Selva-Vera G., and Vieta E. Specificity of cognitive deficits in bipolar disorder versus schizophrenia. a systematic review. Psychother Psychosom 75 (2006) 72-84
22. Egan M.F., Goldberg T.E., Kolachana B.S., Callicott J.H., Mazzanti C.M., Straub R.E., et al. Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci U S A 98 (2001) 6917-6922
23. Endicott J., Andreasen N., and Spitzer R. Family history RDC. 3rd ed. (1978), New York State Psychiatric Institute, Biometrics Research, New York
24. Fatemi S.H., Earle J.A., and McMenomy T. Reduction in Reelin immunoreactivity in hippocampus of subjects with schizophrenia, bipolar disorder and major depression. Mol Psychiatry 5 (2000) 654-663
25. Grayson D.R., Jia X., Chen Y., Sharma R.P., Mitchell C.P., Guidotti A., and Costa E. Reelin promoter hypermethylation in schizophrenia. Proc Natl Acad Sci U S A 102 (2005) 9341-9346
26. Guidotti A., Auta J., Davis J.M., Di-Giorgi-Gerevini V., Dwivedi Y., Grayson D.R., et al. Decrease in Reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder. a postmortem brain study. Arch Gen Psychiatry 57 (2000) 1061-1069
27. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 23 (1960) 56-62
28. Harrison P.J. The neuropathology of primary mood disorder. Brain 125 (2002) 1428-1449
29. Harrison P.J., and Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology. on the matter of their convergence. Mol Psychiatry 10 8 (2005) 804
30. Harwood A.J. Neurodevelopment and mood stabilizers. Curr Mol Med 3 (2003) 472-482
31. Hennah W., Varilo T., Kestila M., Paunio T., Arajarvi R., Haukka J., Parker A., Martin R., Levitzky S., Partonen T., Meyer J., Lonnqvist J., Peltonen L., and Ekelund J. Haplotype transmission analysis provides evidence of association for DISC1 to schizophrenia and suggests sex-dependent effects. Hum Mol Genet 12 (2003) 3151-3159
32. Hodgkinson C.A., Goldman D., Jaeger J., Persaud S., Kane J.M., Lipsky R.H., and Malhotra A.K. Disrupted in schizophrenia 1 (DISC1). association with schizophrenia, schizoaffective disorder, and bipolar disorder. Am J Hum Genet 75 (2004) 862-872
33. Honda A., Ono J., Kurahashi H., Mano T., Imai K., and Okada S. Isolated lissencephaly sequence with balanced chromosome translocation involving 17p13.3. Brain Dev 20 (1998) 190-192
34. Hong S.E., Shugart Y.Y., Huang D.T., Shahwan S.A., Grant P.E., et al. Autosomal recessive lissencephaly with cerebellar hypoplasia is associated with human RELN mutations. Nat Genet 26 (2000) 93-96
35. Hyde T.M., and Lewis S.W. The secondary schizophrenias. In: Hirsch S.R., and Weinberger D.R. (Eds). Schizophrenia (2003), Blackwell Science Ltd, Malden, MA 187-202
36. Kato K., Clark G.D., Bazan N.G., and Zorumski C.F. Platelet-activating factor as a potential retrograde messenger in CA1 hippocampal long-term potentiation. Nature 367 (1994) 175-179
37. Kendler K.S., Karkowski L.M., and Walsh D. The structure of psychosis. latent class analysis of probands from the Roscommon Family Study. Arch Gen Psychiatry 55 (1998) 492-499
38. Knable M.B., Torrey E.F., Webster M.J., and Bartko J.J. Multivariate analysis of prefrontal cortical data from the Stanley Foundation Neuropathology Consortium. Brain Res Bull 55 (2001) 651-659
39. Knable M.B., Barci B.M., Webster M.J., Meador-Woodruff J., and Torrey E.F. Molecular abnormalities of the hippocampus in severe psychiatric illness. postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry 9 (2004) 609-620
40. Kohler A., Hain J., and Muller U. Clinical and molecular genetic findings in five patients with Miller-Dieker syndrome. Clin Genet 47 (1995) 161-164
41. Leal C., Gómez-Beneyto M., De Vicente V., Sanjuán J., and Tabarés-Seisdedos R. Adaptación de la historia familiar RDC para la investigación de la morbilidad psiquiátrica en familiares de pacientes psiquiátricos (1988) Madrid: Actas del II Congreso de la Sociedad Española de Psiquiatría Biológica
42. Lewis D.A., Hashimoto T., and Volk D.W. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci 6 (2005) 312-324
43. Makos M., Nelkin B.D., Chazin V.R., Cavenee W.K., Brodeur G.M., and Baylin S.B. DNA hypermethylation is associated with 17p allelic loss in neural tumors. Cancer Res 15 (1993) 2715-2718
44. Merikangas K.R., Chakravarti A., Moldin S.O., Araj H., Blangero J.C., Burmeister M., et al. Future of genetics of mood disorders research. Biol Psychiatry 52 (2002) 457-477
45. Middleton F.A., Peng L., Lewis D.A., Levitt P., and Mirnics K. Altered expression of 14-3-3 genes in the prefrontal cortex of subjects with schizophrenia. Neuropsychopharmacology 30 (2005) 974-983
46. Millar J.K., Wilson-Annan J.C., Anderson S., Christie S., Taylor M.S., Semple C.A., et al. Disruption of two novel genes by a translocation co-segregating with schizophrenia. Hum Mol Genet 9 (2000) 415-1423
47. Morris J.A., Kandpal G., Ma L., and Austin C.P. DISC1 (Disrupted-In-Schizophrenia 1) is a centrosome-associated protein that interacts with MAP1A, MIPT3, ATF4/5 and NUDEL. regulation and loss of interaction with mutation. Hum Mol Genet 12 (2003) 1591-1608
48. Mutchinick O.M., Shaffer L.G., Kashork C.D., and Cervantes E.I. Miller-Dieker syndrome and trisomy 5p in a child carrying a derivative chromosome with a microdeletion in 17p13.3 telomeric to the LIS1 and the D17S379 loci. Am J Med Genet 85 (1999) 99-104
49. Ni X., Trakalo J., Valente J., Azevedo M.H., Pato M.T., Pato C.N., and Kennedy J.L. Human p53 tumor suppressor gene (TP53) and schizophrenia. case-control and family studies. Neurosci Lett 388 (2005) 173-178
50. Ohtsuki T., Watanabe H., Toru M., and Arinami T. Lack of evidence for associations between plasma platelet-activating factor acetylhydrolase deficiency and schizophrenia. Psychiatry Res 109 (2002) 93-96
51. Oken R.J., and Schulzer M. At issue: schizophrenia and rheumatoid arthritis: the negative association revisited. Schizophr Bull 25 (1999) 625-638
52. Olivier M., Aggarwal A., Allen J., Almendras A.A., Bajorek E.S., Beasley E.M., Brady S.D., Bushard J.M., Bustos V.I., Chu A., Chung T.R., De Witte A., Denys M.E., Dominguez R., Fang N.Y., Foster B.D., Freudenberg R.W., Hadley D., Hamilton L.R., Jeffrey T.J., Kelly L., Lazzeroni L., Levy M.R., Lewis S.C., Liu X., Lopez F.J., Louie B., Marquis J.P., Martinez R.A., Matsuura M.K., Misherghi N.S., Norton J.A., Olshen A., Perkins S.M., Perou A.J., Piercy C., Piercy M., Qin F., Reif T., Sheppard K., Shokoohi V., Smick G.A., Sun W.L., Stewart E.A., Fernando J., Tejeda Tran N.M., Trejo T., Vo N.T., Yan S.C., Zierten D.L., Zhao S., Sachidanandam R., Trask B.J., Myers R.M., and Cox D.R. A high-resolution radiation hybrid map of the human genome draft sequence. Science 291 (2001) 1298-1302
53. Ott (2003) HWE program. http://linkage.rockefeller.edu. Accessed May 2004.
54. Ozeki Y., Tomoda T., Kleiderlein J., Kamiya A., Bord L., Fujii K., et al. Disrupted-in-Schizophrenia-1 (DISC1-1). mutant truncation prevents binding to Nude-like (NUDEL) and inhibits neurite outgrowth. Proc Natl Acad Sci U S A 100 (2003) 289-294
55. Pahnke J., Mix E., Knoblich R., Muller J., Zschiesche M., Schubert B., et al. Overexpression of glial cell line-derived neurotrophic factor induces genes regulating migration and differentiation of neuronal progenitor cells. Exp Cell Res 297 (2004) 484-494
56. Pancoast M., Dobyns W., and Golden J.A. Interneuron deficits in patients with the Miller-Dieker syndrome. Acta Neuropathol (Berl) 109 (2005) 400-404
57. Papiol S., Arias B., Barrantes-Vidal N., Guitart M., Salgado P., Catalan R., and Fañanas L. Analysis of polymorphisms at the tumor suppressor gene p53 (TP53) in contributing to the risk for schizophrenia and its associated neurocognitive deficits. Neurosci Lett 363 (2004) 78-80
58. Peralta V., and Cuesta M.J. Psychometric properties of the Positive and Negative Syndrome Scale (PANSS) in schizophrenia. Psychiatry Res 53 (1994) 31-40
59. Pilz D.T., Macha M.E., Precht K.S., Smith A.C., Dobyns W.B., and Ledbetter D.H. Fluorescence in situ hybridization analysis with LIS1 specific probes reveals a high deletion mutation rate in isolated lissencephaly sequence. Genet Med 1 (1998) 29-33
60. Qin P., Xu H., Laursen T.M., Vestergaard M., and Mortensen P.B. Risk for schizophrenia and schizophrenia-like psychosis among patients with epilepsy. population based cohort study. BMJ 331 (2005) 23
61. Rapoport J.L., Addington A., and Fragou S. The neurodevelopmental model of schizophrenia. update 2005. Mol Psychiatry 10 (2005) 434-449
62. Riley B., Asherson P., and McGuffin P. Genetics and schizophrenia. In: Hirsch S.R., and Weinberger D. (Eds). Schizophrenia (2003), Blackwell Science Ltd, MA 251-276
63. Ross M.E., and Walsh C.A. Human brain malformations and their lessons for neuronal migration. Annu Rev Neurosci 24 (2001) 1041-1070
64. Sachs N.A., Sawa A., Holmes S.E., Ross C.A., DeLisi L.E., and Margolis R.L. A frameshift mutation in Disrupted in Schizophrenia 1 in an American family with schizophrenia and schizoaffective disorder. Mol Psychiatry 10 (2005) 758-764
65. Saxena A., Clark W.C., Robertson J.T., Ikejiri B., Oldfield E.H., and Ali I.U. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas. Cancer Res 52 (1993) 6716-6721
66. Schwartz C.E., Sauer S.M., Brown A.M., Divelbiss J.E., and Patil S.R. Localization of the Miller-Dieker critical region is proximal to locus D17S34 (p144D6) in 17p13.3. Genomics 7 (1990) 621-624
67. Shifman S., Bronstein M., Sternfeld M., Pisante A., Weizman A., Reznik I., Spivak B., Grisaru N., Karp L., Schiffer R., Kotler M., Strous R.D., Swartz-Vanetik M., Knobler H.Y., Shinar E., Yakir B., Zak N.B., and Darvasi A. COMT. a common susceptibility gene in bipolar disorder and schizophrenia. Am J Med Genet 128B (2004) 61-64
68. Shinya M., Okamoto A., Sago H., Saito M., Akiyama Y., Kitagawa M., and Tanaka T. Analysis of fetal DNA from maternal peripheral blood by lectin-polymerase chain reaction-single strand conformation polymorphism. Congenit Anom (Kyoto) 44 (2004) 142-146
69. Shu T., Ayala R., Nguyen M.D., Xie Z., Gleeson J.G., and Tsai L.H. Ndel1 operates in a common pathway with LIS1 and cytoplasmic dynein to regulate cortical neuronal positioning. Neuron 44 (2004) 263-277
70. Smith A.G., Popov N., Imreh M., Axelson H., and Henriksson M. Expression and DNA-binding activity of MYCN/Max and Mnt/Max during induced differentiation of human neuroblastoma cells. J Cell Biochem 92 (2004) 1282-1295
71. St. Clair D., Blackwood D., Muir W., Carothers A., Walker M., Spowart G., et al. Association within a family of a balanced autosomal translocation with major mental illness. Lancet 336 (1990) 13-16
72. Tabarés-Seisdedos R., Balanzá-Martínez V., Salazar-Fraile J., Selva-Vera G., Leal-Cercos C., and Gomez-Beneyto M. Specific executive/attentional deficits in patients with schizophrenia or bipolar disorder who have a positive family history of psychosis. J Psychiatry Res 37 (2003) 479-486
73. Tanaka T., Serneo F.F., Higgins C., Gambello M.J., Wynshaw-Boris A., and Gleeson J.G. Lis1 and doublecortin function with dynein to mediate coupling of the nucleus to the centrosome in neuronal migration. J Cell Biol 165 (2004) 709-721
74. Tarricone C., Perrina F., Monzani S., Massimiliano L., Kim M.H., Derewenda Z.S., et al. Coupling PAF signaling to dynein regulation. structure of LIS1 in complex with PAF-acetylhydrolase. Neuron 44 (2004) 809-821
75. Toh W.H., Kyo S., and Sabapathy K. Relief of p53-mediated telomerase suppression by p73 (2005). J Biol Chem 280 (2005) 17329-17338
76. Tokuoka S.M., Ishii S., Kawamura N., Satoh M., Shimada A., Sasaki S., et al. Involvement of platelet-activating factor and LIS1 in neuronal migration. Eur J Neurosci 18 (2003) 563-570
77. Torrey E.F. Epidemiological comparison of schizophrenia and bipolar disorder. Schizophr Res 39 (1999) 101-106
78. Toyo-oka K., Shionoya A., Gambello M.J., Cardoso C., Leventer R., Ward H.L., et al. 14-3-3epsilon Is important for neuronal migration by binding to NUDEL. a molecular explanation for Miller-Dieker syndrome. Nat Genet 34 (2003) 274-285
79. Tsuchiya E., Tanigami A., Ishikawa Y., Nishida K., Hayashi M., Tokuchi Y., Hashimoto T., Okumura S., Tsuchiya S., and Nakagawa K. Three new regions on chromosome 17p13.3 distal to p53 with possible tumor suppressor gene involvement in lung cancer. Jpn J Cancer Res 91 (2000) 589-596
80. van Tuinen P., Dobyns W.B., Rich D.C., Summers K.M., Robinson T.J., Nakamura Y., and Ledbetter D.H. Molecular detection of microscopic and submicroscopic deletions associated with Miller-Dieker syndrome. Am J Hum Genet 43 (1988) 587-596
81. Vázquez-Barquero J.L. SCAN. Cuestionarios para la evaluación clínica en neuropsiquiatría (adaptación al español) (1993), Servicio de Psiquiatría, Hospital Universitario 'Marqués de Valdecilla', Santander
82. Weinberger D.R., Egan M.F., Bertolino A., Callicott J.H., Mattay V.S., Lipska B.K., et al. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 50 (2001) 825-844
83. Xu Y., and Tao Y.X. Involvement of the NMDA receptor/nitric oxide signal pathway in platelet-activating factor-induced neurotoxicity. Neuroreport 15 (2004) 263-266
84. Yan W., Assadi A.H., Wynshaw-Boris A., Eichele G., Matzuk M.M., and Clark G.D. Previously uncharacterized roles of platelet-activating factor acetylhydrolase 1b complex in mouse spermatogenesis. Proc Natl Acad Sci U S A 100 (2003) 7189-7194